tetano
Editor, Senior Moderator
J Virol Methods. 2013 Jul 22. pii: S0166-0934(13)00275-9. doi: 10.1016/j.jviromet.2013.07.021. [Epub ahead of print]
Improved Dual Promotor-Driven Reverse Genetics System for Influenza Viruses.
Mostafa A, Kanrai P, Ziebuhr J, Pleschka S.
Source
Institute of Medical Virology, Justus Liebig University Giessen, BFS, Schubertstrasse 81, 35392 Giessen, Germany; Virology Laboratory, Environmental Research Division, National Research Center, 12311 Dokki, Giza, Egypt. Electronic address: ahmed.m.elsayed@bio.uni-giessen.de.
Abstract
Reverse genetic systems for influenza A virus (IAV) allow the generation of genetically manipulated infectious virus from a set of transfected plasmid DNAs encoding the eight genomic viral RNA segments (vRNA). For this purpose, cDNAs representing these eight vRNA segments are cloned into specific plasmid vectors that allow the generation of vRNA-like transcripts using polymerase I (Pol I). In addition, these plasmids support the transcription of viral mRNA by polymerase II (Pol II), leading to the expression of viral protein(s) encoded by the respective transcripts. In an effort to develop this system further, we constructed the bi-directional vector pMPccdB. It is based on pHW2000 (Hoffmann et al., 2000b) but contains additionally (i) the ccdB gene whose expression is lethal for most Escherichia coli strains and therefore used as a negative selection marker and (ii) more efficient AarI cloning sites that flank the ccdB gene on either side. Furthermore, we used a modified one-step restriction/ligation protocol to insert the desired cDNA into the respective pMPccdB vector DNA. Both the use of a negative selection marker and an improved cloning protocol were shown to facilitate the generation of genetically engineered IAV as illustrated in this study by the cloning and rescue of the 2009 pandemic isolate A/Giessen/6/2009 (Gi-H1N1).
Copyright ? 2013. Published by Elsevier B.V.
KEYWORDS:
BGH, Bovine growth hormone, CEF, Chicken embryo fibroblast, Cloning vector, FFU, Focus-forming units, Influenza virus, Pandemic, Pdm, Reverse genetic systems, recombinant generated, rg
PMID:
23886561
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/23886561
Improved Dual Promotor-Driven Reverse Genetics System for Influenza Viruses.
Mostafa A, Kanrai P, Ziebuhr J, Pleschka S.
Source
Institute of Medical Virology, Justus Liebig University Giessen, BFS, Schubertstrasse 81, 35392 Giessen, Germany; Virology Laboratory, Environmental Research Division, National Research Center, 12311 Dokki, Giza, Egypt. Electronic address: ahmed.m.elsayed@bio.uni-giessen.de.
Abstract
Reverse genetic systems for influenza A virus (IAV) allow the generation of genetically manipulated infectious virus from a set of transfected plasmid DNAs encoding the eight genomic viral RNA segments (vRNA). For this purpose, cDNAs representing these eight vRNA segments are cloned into specific plasmid vectors that allow the generation of vRNA-like transcripts using polymerase I (Pol I). In addition, these plasmids support the transcription of viral mRNA by polymerase II (Pol II), leading to the expression of viral protein(s) encoded by the respective transcripts. In an effort to develop this system further, we constructed the bi-directional vector pMPccdB. It is based on pHW2000 (Hoffmann et al., 2000b) but contains additionally (i) the ccdB gene whose expression is lethal for most Escherichia coli strains and therefore used as a negative selection marker and (ii) more efficient AarI cloning sites that flank the ccdB gene on either side. Furthermore, we used a modified one-step restriction/ligation protocol to insert the desired cDNA into the respective pMPccdB vector DNA. Both the use of a negative selection marker and an improved cloning protocol were shown to facilitate the generation of genetically engineered IAV as illustrated in this study by the cloning and rescue of the 2009 pandemic isolate A/Giessen/6/2009 (Gi-H1N1).
Copyright ? 2013. Published by Elsevier B.V.
KEYWORDS:
BGH, Bovine growth hormone, CEF, Chicken embryo fibroblast, Cloning vector, FFU, Focus-forming units, Influenza virus, Pandemic, Pdm, Reverse genetic systems, recombinant generated, rg
PMID:
23886561
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/23886561